Vanguard Group Inc. Grows Holdings in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI)
otakuyassine3@gmail.com Vanguard Group Inc. raised its holdings in shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Free...
Therapies
Brokerages Set Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Target Price at $106.08
Shares of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI – Get Free Report) have received an average rating...
Financial Contrast: Taysha Gene Therapies (NASDAQ:TSHA) versus AIM ImmunoTech (NYSE:AIM)
Taysha Gene Therapies (NASDAQ:TSHA – Get Free Report) and AIM ImmunoTech (NYSE:AIM – Get Free...